Gerald Owen Schaefer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gerald Owen Schaefer has a total of 103 co-authors. Here are the top co-authors by number of shared publications:
- Julian Savulescu
National University of Singapore
11 shared publications - Vicki Xafis
Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
6 shared publications Angela Ballantyne
Department of Primary Health Care & General Practice, University of Otago, Wellington, New Zealand
5 shared publications- E. Shyong Tai
Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore
5 shared publications - Anantharaman Muralidharan
Centre for Biomedical Ethics, Yong Loo Lin School of Medicine National University of Singapore Singapore Singapore
4 shared publications - Hui Jin Toh
National University of Singapore
4 shared publications
Latest Publications
- Open Access
- 27 October 2026
- Published by SAGE Publications in Big Data & Society
- Vol. 13 (4)
Research data governance: A qualitative study of public views on data visiting, researcher reputability and public engagement in Singapore
Background: Government-funded data platforms worldwide link diverse datasets for secondary research. Their functioning relies on public trust, which requires understanding public perspectives on data governance and aligning policies where possible. This study explores public perspectives on three key aspects of data governance in Singapore: data access methods, researcher credibility assessment and public involvement models. Methods: We conducted four focus group discussions ( n = 38) with Singapore citizens and permanent residents from the Health Opinion Panel Singapore (HOPS) panel. Discussions explored preferences regarding data visiting versus data sharing, characteristics of reputable researchers and models for incorporating public input into governance. Transcripts were analysed using reflexive thematic analysis. Results: Our analysis identified four key themes. First, participants preferred governance controls over technical protections, valuing oversight regardless of access method. Second, trustworthiness rather than reputation was prioritized, with personal integrity and research purpose considered more important than institutional affiliation. Third, participants preferred balanced approaches to public involvement incorporating diverse perspectives while maintaining efficiency. Finally, participants expressed concerns about societal harms beyond individual privacy, including commercial exploitation, community stigmatization and impacts on vulnerable populations. Conclusions: Our findings suggest that data governance should prioritize transparency, meaningful public involvement and comprehensive assessment of trustworthiness to maintain public trust and social license to operate. Technical approaches like data visiting must be complemented by robust governance frameworks incorporating public values and addressing long-term societal impacts. As health data platforms evolve globally, incorporating diverse public perspectives in governance can enhance legitimacy, strengthen accountability and ensure research contributes to public benefit.
- 27 October 2026
- Published by SAGE Publications in Big Data & Society
- Vol. 13 (4)
Open AccessResearch data governance: A qualitative study of public views on data visiting, researcher reputability and public engagement in Singapore
Background: Government-funded data platforms worldwide link diverse datasets for secondary research. Their functioning relies on public trust, which requires understanding public perspectives on data governance and aligning policies where possible. This study explores public perspectives on three key aspects of data governance in Singapore: data access methods, researcher credibility assessment and public involvement models. Methods: We conducted four focus group discussions ( n = 38) with Singapore citizens and permanent residents from the Health Opinion Panel Singapore (HOPS) panel. Discussions explored preferences regarding data visiting versus data sharing, characteristics of reputable researchers and models for incorporating public input into governance. Transcripts were analysed using reflexive thematic analysis. Results: Our analysis identified four key themes. First, participants preferred governance controls over technical protections, valuing oversight regardless of access method. Second, trustworthiness rather than reputation was prioritized, with personal integrity and research purpose considered more important than institutional affiliation. Third, participants preferred balanced approaches to public involvement incorporating diverse perspectives while maintaining efficiency. Finally, participants expressed concerns about societal harms beyond individual privacy, including commercial exploitation, community stigmatization and impacts on vulnerable populations. Conclusions: Our findings suggest that data governance should prioritize transparency, meaningful public involvement and comprehensive assessment of trustworthiness to maintain public trust and social license to operate. Technical approaches like data visiting must be complemented by robust governance frameworks incorporating public values and addressing long-term societal impacts. As health data platforms evolve globally, incorporating diverse public perspectives in governance can enhance legitimacy, strengthen accountability and ensure research contributes to public benefit.
- Open Access
- 9 September 2026
- Published by Taylor & Francis in The American Journal of Bioethics
- p. 1-18
The Ethics of Growth-Promoting Pharmaceuticals for Achondroplasia
- 9 September 2026
- Published by Taylor & Francis in The American Journal of Bioethics
- p. 1-18
Open AccessThe Ethics of Growth-Promoting Pharmaceuticals for Achondroplasia
- 3 September 2026
- Published by Springer Nature in Neuroethics
- Vol. 19 (3) , 45
A Scoping Review of Ethical Considerations in the Use of AI for Bereavement-related Grief Support
- 3 September 2026
- Published by Springer Nature in Neuroethics
- Vol. 19 (3) , 45
A Scoping Review of Ethical Considerations in the Use of AI for Bereavement-related Grief Support
- Open Access
- 7 May 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (10) , 3576
Guiding Policymakers Toward Better AI Ethics Integration in Healthcare Regulation—Lessons from Singapore
In terms of rollout, comprehensiveness, and strategy, Singapore’s regulatory landscape governing the ethical use of Artificial Intelligence (AI) in healthcare has generally kept pace with other global leaders in AI advancement. However, establishing a robust and holistic regulatory framework that evolves along with emerging technologies is not easy—especially in healthcare, where the stakes are high and resources may be limited. We conducted a structured scoping analysis of key AI regulatory and professional documents in Singapore, selected using predefined inclusion criteria. Documents were systematically mapped against Savulescu et al.’s nine categories of ethical risk, followed by cross-document comparison to identify integration gaps and inconsistencies, and benchmarking against international AI governance frameworks. These recommendations are generalizable beyond Singapore for developers, implementers, healthcare professionals and patients and include dealing with bias in AI, enhancing human productivity without deskilling, facilitating more informed decision-making, and cultivating greater knowledge exchange between clinicians and patients, to name a few.
- 7 May 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (10) , 3576
Open AccessGuiding Policymakers Toward Better AI Ethics Integration in Healthcare Regulation—Lessons from Singapore
In terms of rollout, comprehensiveness, and strategy, Singapore’s regulatory landscape governing the ethical use of Artificial Intelligence (AI) in healthcare has generally kept pace with other global leaders in AI advancement. However, establishing a robust and holistic regulatory framework that evolves along with emerging technologies is not easy—especially in healthcare, where the stakes are high and resources may be limited. We conducted a structured scoping analysis of key AI regulatory and professional documents in Singapore, selected using predefined inclusion criteria. Documents were systematically mapped against Savulescu et al.’s nine categories of ethical risk, followed by cross-document comparison to identify integration gaps and inconsistencies, and benchmarking against international AI governance frameworks. These recommendations are generalizable beyond Singapore for developers, implementers, healthcare professionals and patients and include dealing with bias in AI, enhancing human productivity without deskilling, facilitating more informed decision-making, and cultivating greater knowledge exchange between clinicians and patients, to name a few.
- 5 May 2026
- Published by Springer Nature in Asian Bioethics Review
- Vol. 18 (4) , 847-868
Trustworthy Governance of Genomic and Health-Related Data: Lessons from Singapore
- 5 May 2026
- Published by Springer Nature in Asian Bioethics Review
- Vol. 18 (4) , 847-868
Trustworthy Governance of Genomic and Health-Related Data: Lessons from Singapore
- Open Access
Public Justification and Normatively Meaningful Bias: Against Imposing Egalitarian Accounts of Algorithmic Bias
In a number of policy, institutional, activist and advocacy contexts, attributing bias to an algorithm does not just describe the algorithm but also imposes a particular, normatively laden conception of bias on others. Given the normative content of such bias attributions, this would involve making moral demands on others to rectify the algorithm, compensate the victims of such bias and/or not unselectively deploy the algorithm. It is also the case that moral demands, especially in the above‐mentioned contexts, are subject to a public justification requirement. As it turns out, the dominant accounts of bias in the literature presuppose some version of egalitarianism about justice and that any action that causally contributes to an unjust situation is itself wrong. Since these presuppositions are subject to reasonable disagreement, bias attributions in such situations are wrong because they violate the public justification requirement. In response, we develop a publicly justifiable conception of algorithmic bias.
Open AccessPublic Justification and Normatively Meaningful Bias: Against Imposing Egalitarian Accounts of Algorithmic Bias
In a number of policy, institutional, activist and advocacy contexts, attributing bias to an algorithm does not just describe the algorithm but also imposes a particular, normatively laden conception of bias on others. Given the normative content of such bias attributions, this would involve making moral demands on others to rectify the algorithm, compensate the victims of such bias and/or not unselectively deploy the algorithm. It is also the case that moral demands, especially in the above‐mentioned contexts, are subject to a public justification requirement. As it turns out, the dominant accounts of bias in the literature presuppose some version of egalitarianism about justice and that any action that causally contributes to an unjust situation is itself wrong. Since these presuppositions are subject to reasonable disagreement, bias attributions in such situations are wrong because they violate the public justification requirement. In response, we develop a publicly justifiable conception of algorithmic bias.
- 26 October 2025
- Published by Elsevier in Best Practice & Research Clinical Obstetrics & Gynaecology
- Vol. 103, 102678
The future of clinical studies of in-utero therapy for genetic diseases
- 26 October 2025
- Published by Elsevier in Best Practice & Research Clinical Obstetrics & Gynaecology
- Vol. 103, 102678
The future of clinical studies of in-utero therapy for genetic diseases
- 29 July 2025
- Published by BMJ in Journal of Medical Ethics
- Vol. 52 (12) , 841-848
Why de-identified data sharing for research should be in the public interest
‘Advancing the public interest’ is a criterion for de-identified data use for research via several national data platforms and biobanks. This may be referred to via cognate terms such as public benefit, public good or social value. The criterion is often adopted without it being a legal requirement. It is a legal requirement in some jurisdictions for sharing identifiable data without consent, which does not apply to de-identified data. We argue that, even in circumstances where there are few or no legal restrictions on the sharing of de-identified data, there is a sound ethical reason for platforms to nevertheless impose a public interest criterion on data sharing. We argue that a public interest test is ethically essential for justifying research use of de-identified data via government-funded platforms because (1) it allows to promote public good and to minimise potential harmful consequences of research for both individuals and groups, for example, by offering grounds to reject research that could lead to stigmatisation of marginalised populations; (2) national data platforms hold public data and are made possible by government funds, and therefore should be used to support public interests and (3) it can demonstrate trustworthiness and contribute to promoting the social licence for data platforms to operate, which is especially important for efforts to align data governance policies with public norms and expectations.
- 29 July 2025
- Published by BMJ in Journal of Medical Ethics
- Vol. 52 (12) , 841-848
Why de-identified data sharing for research should be in the public interest
‘Advancing the public interest’ is a criterion for de-identified data use for research via several national data platforms and biobanks. This may be referred to via cognate terms such as public benefit, public good or social value. The criterion is often adopted without it being a legal requirement. It is a legal requirement in some jurisdictions for sharing identifiable data without consent, which does not apply to de-identified data. We argue that, even in circumstances where there are few or no legal restrictions on the sharing of de-identified data, there is a sound ethical reason for platforms to nevertheless impose a public interest criterion on data sharing. We argue that a public interest test is ethically essential for justifying research use of de-identified data via government-funded platforms because (1) it allows to promote public good and to minimise potential harmful consequences of research for both individuals and groups, for example, by offering grounds to reject research that could lead to stigmatisation of marginalised populations; (2) national data platforms hold public data and are made possible by government funds, and therefore should be used to support public interests and (3) it can demonstrate trustworthiness and contribute to promoting the social licence for data platforms to operate, which is especially important for efforts to align data governance policies with public norms and expectations.
- 4 May 2025
- Published by Taylor & Francis in The American Journal of Bioethics
- Vol. 25 (5) , 89-91
Decentralized Trials: Let’s Not Overthink It
- 4 May 2025
- Published by Taylor & Francis in The American Journal of Bioethics
- Vol. 25 (5) , 89-91
Decentralized Trials: Let’s Not Overthink It
- Open Access
- 25 February 2025
- Published by BMJ in Journal of Medical Ethics
- Vol. 51 (11) , 747-753
Singaporean attitudes to cognitive enhancement: a cross-sectional survey
Recent developments in genetic technologies have provided prospective parents with increasing opportunities to influence their future child’s phenotype. This study aimed to understand public attitudes towards gene-based technologies and services, with a particular focus on improving educational outcomes. We conducted a cross-sectional survey among a Singaporean population (n=1438), adapting a survey instrument previously used in the US context. Our results suggested that Singaporeans had a greater moral acceptance of, and willingness to use, genetic technologies and services compared with the US population. Among the technologies examined, the use of polygenic embryo screening was considered more acceptable than gene editing. While these public attitudes show some support for the use of these technologies, further research and consultation among multiple stakeholder groups is necessary to determine whether such technology should be used and how it should be regulated.
- 25 February 2025
- Published by BMJ in Journal of Medical Ethics
- Vol. 51 (11) , 747-753
Open AccessSingaporean attitudes to cognitive enhancement: a cross-sectional survey
Recent developments in genetic technologies have provided prospective parents with increasing opportunities to influence their future child’s phenotype. This study aimed to understand public attitudes towards gene-based technologies and services, with a particular focus on improving educational outcomes. We conducted a cross-sectional survey among a Singaporean population (n=1438), adapting a survey instrument previously used in the US context. Our results suggested that Singaporeans had a greater moral acceptance of, and willingness to use, genetic technologies and services compared with the US population. Among the technologies examined, the use of polygenic embryo screening was considered more acceptable than gene editing. While these public attitudes show some support for the use of these technologies, further research and consultation among multiple stakeholder groups is necessary to determine whether such technology should be used and how it should be regulated.